Anti-SARS-CoV-2 S-RBD protein Human IgG ELISA Kit


6.25-200 ng/mL

Cat no : KE30003


Anti-SARS-CoV-2 S-RBD protein Human IgG, COVID-19, S protein, Spike, Spike protien

Product Information

KE30003 is a quantitative measurement of the human IgG for 2019-nCoV S-RBD in serum and plasma. The principle of the kit is indirect ELISA. S-RBD Recombinant Protein has been pre-coated onto microplate well. The samples or standard are added to the well, after incubation the wells are washed and a horseradish peroxidase conjugated anti-Human IgG is added to each well. Producing an complex " Recombinant Protein-human anti-S-RBD IgG antibody-HRP conjugated antibody". after incubation the wells are washed, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450nm with the correction wavelength set at 630 nm.

Product name Anti-SARS-CoV-2 S-RBD protein Human IgG ELISA Kit
Tests 1 X 96 well plate
Sample type Serum, Plasma
Assay type Indirect
Sensitivity N/A
Range 6.25-200 ng/mL
Tested applications Indirect ELISA
Gene ID (NCBI) 43740568

Background Information

A promising target for both diagnosis and therapeutics treatments of the new disease named COVID-19 is the coronavirus (CoV) spike (S) glycoprotein. The spike protein, which is responsible for the "corona" (Latin word for crown) appearance in all coronaviruses, is a type I glycoprotein that has an especial role in the interaction between the virus and the host cell. This protein attaches itself to specific cellular receptors and suffers a conformational change that enables the fusion of the virus and the cell (1). Studies have shown that the SARS-CoV-2's S RBD protein interacts strongly with the Angiotensin-converting enzyme 2 (ACE2). S-RBD protein in order to enlighten the binding epitopes of these Abs. Because of the conservation of S-RBD protein sequence and its strong immunogenicity, the S-RBD protein of coronavirus is chosen as a diagnostic tool. COVID-19 antibodies can be produced by a host immune system following exposure to SARS-CoV-2. IgG and IgM antibodies are also known as immunoglobulins G and M, respectively, and are among the antibody isotypes produced by vertebrate immune systems.The ELISA microplate is coated with the SARS-CoV-2 S-RBD protein. The coated S-RBD protein binds with COVID-19 IgG S-RBD antibodies in the serum sample.


Storage Instructions All the reagents are stored at 2-8℃ for 6 months or -20℃ for 12 months. Refer to the protocol for further storage instructions.
Synonyms Anti-SARS-CoV-2 S-RBD protein Human IgG, COVID-19, S protein, Spike, Spike protien


SpeciesSample TypeTitle


SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19

Authors - Ying-Chuan Wang

Front Immunol

An Integrated Platform for Serological Detection and Vaccination of COVID-19.

Authors - Sung-Chan Wei

Sci Rep

Neutralizing immunity against coronaviruses in Tanzanian health care workers

Authors - Godfrey Barabona

Breast Cancer Res Treat

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study

Authors - Mitsuo Terada

Front Med

Early assessment of the safety and immunogenicity of a third dose (booster) of COVID-19 immunization in Chinese adults.

Authors - Yuntao Zhang

Front Med

Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.

Authors - Yun Tan